Date created

Resolution to apply for revocation of shares’ admission to trading on the regulated market

Today, the Management Board of Celesio AG (Company) with registered office in Stuttgart, ISIN DE000CLS 1001, has resolved, with the approval of the supervisory board, to file an application with the stock exchanges where the Company’s shares are listed in the regulated market, for revocation of admission to the regulated market (so-called delisting). The shares of Celesio AG are currently admitted to trading on the segment of the regulated market with additional post-admission obligations (Prime Standard) of the Frankfurt Stock Exchange (Frankfurter Wertpapierbörse) as well as to trading on the regulated market at the stock exchanges Berlin, Düsseldorf, Stuttgart and Munich.

Questions and answers on an application for delisting (PDF 33 KB)

In addition, the management board resolved, in the context of the application for revocation of the admission to trading on the regulated market, at the stock exchanges in Düsseldorf and Munich to apply for the shares to be included in trading on the regulated unofficial markets (Freiverkehr) in the segment primary market (Primärmarkt) (Düsseldorf) and in the segment m:access (Munich), respectively.

The existing inclusion of the Company’s shares in the regulated unofficial markets of the stock exchanges in Hamburg and Hanover would not be affected by the applications filed with the stock exchanges in Frankfurt, Berlin, Düsseldorf, Stuttgart and Munich.

After approval of the application for revocation of the admission by the relevant stock exchanges the Company’s shares would then no longer be traded on any regulated market of any stock exchange. Currently the management board of the Company is expecting the shares not to be traded any more on any regulated market six months after the revocation decision of the Frankfurt Stock Exchange has been published.

About Celesio Group
Celesio is a leading international wholesale and retail company and provider of logistics and services to the pharmaceutical and healthcare sectors. The proactive and preventive approach ensures that patients receive the products and support that they require for optimum care. With some 39,000 employees, Celesio operates in 14 countries around the world. Every day, the group serves over 2 million customers – at about 2,200 pharmacies of its own and over 4,300 participants in brand partnership schemes. With 133 wholesale branches, Celesio supplies 65,000 pharmacies and hospitals every day with up to 130,000 pharmaceutical products. The services benefit a patient pool of about 15 million per day.

Investor Relations

Press contact

Creditor Relations